OB/GYN Clinical Alert
RSSArticles
-
Breast Cancer and Hormonal Contraception: New Information or Sensationalism?
Highly publicized results from the Danish database demonstrate an increase in the risk of breast cancer associated with current use of hormonal contraception. Consistent with prior research, the risk is small, confined to current users, and disappears following discontinuation.
-
Does Postpartum Use of Hormonal Contraception Increase Risk of Depression?
An analysis of a large insurance database showed no consistent effect between postpartum initiation of hormonal contraception and the subsequent diagnosis of depression.
-
Should Endocervical Curettage Be Performed Routinely During Colposcopy?
In this study, routine endocervical curettage (ECC) among women age 30 and older detected CIN 2 or worse in 14.4% of cases with higher likelihood of detection among women with high-grade squamous intraepithelial lesion, ASC-H, positive HPV 16 infection, or high grade colposcopic impression. The additional yield of ECC over lesion-directed ectocervical biopsies decreased with each additional biopsy.
-
Dating Pregnancy: What Is the Most Accurate Method?
The NICHD Fetal Growth Studies – Singletons investigation recently yielded a new formula for determining gestational age based on standard biometric information. When compared to an often-used formula, it appeared to be more accurate after 21 weeks of gestation.
-
What Do the Urinary Microbiota and Incontinence Have to Do With Each Other?
Increased diversity of the microbiota in women is associated with urgency urinary incontinence symptoms but not with stress urinary incontinence symptoms.
-
Update on Postpartum Hemorrhage
In the United States, postpartum hemorrhage accounts for 11.4% of maternal deaths, the fourth most common cause after cardiovascular diseases, non-cardiovascular diseases, and infection; worldwide, it is the leading cause of maternal mortality. This feature will discuss the latest treatments for managing postpartum hemorrhage.
-
Hormone Replacement: Have We Made Progress Since WHI?
Vaginal estrogen may improve vaginal symptoms of menopause and does not increase the risk for endometrial cancer, stroke, or cardiovascular disease.
-
Trends in OB/GYN Malpractice Litigation
In this review of medicolegal claims data from 2005-2014, obstetric and gynecologic surgery had the second highest average indemnity payment compared to other specialties, topped only by neurosurgery. Of the 10,915 claims identified, the majority (60%) were dropped, withdrawn, or dismissed; 31.1% of claims were paid by the defendant (90% before trial); and 7.5% were successfully defended by the physician.
-
New Treatment Option for Women at Risk of Fragility Fractures
A randomized trial demonstrated a reduced risk of fragility fractures in high-risk women with osteoporosis treated monthly with the monoclonal antibody romosozumab compared with weekly alendronate.
-
Management of Chronic Hypertension in Pregnancy
Chronic hypertension complicates about 5% of pregnancies and has been associated with higher rates of intrauterine growth restriction (IUGR), stillbirth, and, most importantly, superimposed preeclampsia. Although the condition is far from being solved, there have been some major inroads made into its understanding through contemporary investigation.